Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co.
id:
ariad-pharmaceuticals-inc-v-eli-lilly-co-192-5927512
title:
Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co.
text:
Ariad Pharmaceuticals et al. v. Eli Lilly and Company, 598 F.3d 1336, is a United States court case regarding accusations of infringement by Eli Lilly on U.S. patent 6,410,516 held by ARIAD Pharmaceuticals. The Federal Circuit ruled en banc to invalidate the patent for a lack of sufficient description of the invention. Amici briefing before the en banc panel was intensive, with 26 separate briefs filed, and the final decision has been heavily discussed by legal commentators. Its ultimate impact
brand slug:
wiki
category slug:
encyclopedia
description:
original url:
https://en.wikipedia.org/wiki/Ariad_Pharmaceuticals,_Inc._v._Eli_Lilly_%26_Co.
date created:
date modified:
2023-09-13T01:46:10Z
main entity:
{"identifier":"Q4790159","url":"https://www.wikidata.org/entity/Q4790159"}
image:
fields total:
13
integrity:
13